Clostridium difficle (C. diff) is a well known cause of infectious diarrhea across hospitals in the developed world. An anaerobic, gram positive rod bacteria, C. diff is part of the normal flora of the human colon; however, alterations to the microbiome can promote proliferation leading to pathogenic behavior. Typical symptoms include watery diarrhea in excess of three or more times a day, for at least two days, and abdominal cramping. While most infections do not lead to long term complications, the two complications that are most deleterious to health are toxic megacolon and bowel perforation. Patients with an inflammatory bowel disease are at a higher risk of complications, and thus need to be managed appropriately. This case presents a 39-year-old male, with pertinent medical history of poorly controlled ulcerative colitis, who presented to general surgery with imaging suggesting rectal perforation secondary to a C. diff infection. Due to the free air visualized in the rectum, the patient was urgently transported to the operating room to undergo a total colectomy and end ileostomy surgery. This case discusses the well-known complication of bowel perforation, in order to raise awareness about the management and guidelines. This case is important and significant as it details the appropriate guidelines and structure to follow amongst this unique, and vulnerable to complications, population in order to manage a potentially devastating manifestation of C. diff.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168998 | PMC |
http://dx.doi.org/10.7759/cureus.14751 | DOI Listing |
J Family Med Prim Care
July 2024
Department of Internal Medicine, Creighton University School of Medicine, United States.
Immune check-point inhibitors (ICPi) are immunomodulating agents, which have revolutionized the management of advanced metastatic cancers. Being immunomodulating agents, they are predisposed to causing colitis. This descriptive review article emphasized on the management of ICPi-associated colitis in advanced metastatic cancers.
View Article and Find Full Text PDFCureus
June 2024
Family Medicine, Burrell College of Osteopathic Medicine, Las Cruces, USA.
Fecal microbiota transplantation is an evidence-based therapeutic option for recurrent infection, involving the transfer of healthy donor fecal material to restore gut microbial balance. Despite meticulous donor screening, , a prevalent cause of bacterial gastroenteritis, is not routinely tested, potentially impacting fecal microbiota transplant safety. We present a case of a female with recurrent infection treated with fecal microbiota transplantation, complicated by a subsequent infection.
View Article and Find Full Text PDFJ Infect Chemother
August 2024
Department of Laboratory Medicine/Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University, Japan.
Cureus
May 2023
Infectious Diseases, Dr. Sulaiman Al Habib Medical Group, Khobar, SAU.
Background: () is a common cause of hospital-acquired diarrhea. It is associated with significantly higher mortality and morbidity in addition to the cost-effectiveness burden on the healthcare system. The primary risk factors for infection (CDI) are past exposure, proton pump inhibitors, and antibiotic usage.
View Article and Find Full Text PDFCureus
April 2023
Gastroenterology and Hepatology, Albany Medical Center, Albany, USA.
Introduction colonizes the large intestine, rendering healthy individuals asymptomatic carriers of the disease. In certain instances, infection (CDI) occurs. Antibiotic use remains the leading risk factor for CDI.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!